MLT study materials
MLT study resources

Platelet Fall on Post-Operative Day Six

MLT · Put your knowledge to work in context.

All case studies

Platelet Fall on Post-Operative Day Six

A 67-year-old woman is on post-operative day 6 after coronary artery bypass grafting. She received unfractionated heparin intraoperatively and has been on subcutaneous heparin 5000 units twice daily for DVT prophylaxis since day 1. Platelet counts: pre-op 245, day 1 210, day 3 182, day 5 141, day 6 96 x10^9/L. She has no bleeding, no new thrombosis, no fever, no sepsis, and is on no other drug known to cause thrombocytopenia; coagulation studies show no disseminated intravascular coagulation. The surgical team asks whether the fall is simply post-operative and whether heparin can continue. The laboratory offers a PF4/heparin IgG ELISA (24-hour turnaround) and sends confirmatory serotonin release assays out (5 days).

1. Calculate the 4Ts score and state what it means for management tonight.

Read the worked answer

4Ts calculation:

  • Thrombocytopenia: platelet fall from 245 to 96 is greater than 50%, nadir well above 10 - 2 points.
  • Timing: the fall begins between day 5 and day 10 of heparin exposure, with a clear drop from day 5 to day 6 - 2 points.
  • Thrombosis: none evident - 0 points.
  • Other causes of thrombocytopenia: no sepsis, no DIC, no other culprit drug - 2 points.

Total: 6 - high probability.

Management tonight (do not wait for the assay):

  1. Stop all heparin, including subcutaneous doses, line flushes, and heparin-coated catheters.
  2. Start a non-heparin anticoagulant (argatroban or bivalirudin; danaparoid where available) at therapeutic dose, adjusted for renal and hepatic function.
  3. Do not transfuse platelets prophylactically.
  4. Do not start warfarin alone - risk of venous limb gangrene and skin necrosis; warfarin is only overlapped after platelet recovery.
  5. Send the PF4 ELISA now and document the heparin exposure in the chart with an allergy alert.

The pretest probability drives treatment; the laboratory test confirms and guides duration.

2. How do you interpret the PF4/heparin ELISA result, and what is the role of the serotonin release assay?

Read the worked answer

The ELISA detects antibodies against the PF4/heparin complex and is sensitive but not specific; it is a rule-out test, not a rule-in test.

Interpretation by optical density:

  • Negative (OD below cutoff): high negative predictive value - HIT is effectively excluded in a patient with this presentation, and heparin could be restarted once the clinical picture is clear.
  • Weak positive (OD just above cutoff, e.g. 0.4-1.0): poor specificity; many positive results are non-pathogenic. In a high 4T patient, continue to treat as HIT until the functional assay returns.
  • Strong positive (OD well above 1.0-2.0): correlates better with clinically significant HIT.

Serotonin release assay: the functional confirmatory test, using donor platelets and radiolabelled serotonin, with heparin at therapeutic and supratherapeutic concentrations. It detects platelet-activating antibodies and is far more specific. Results take days, so the decision to stop heparin and anticoagulate is made clinically, and the SRA determines duration (typically 4 weeks to 3 months of anticoagulation, longer if thrombosis) and whether heparin can ever be re-exposed.

3. The ELISA returns with an OD of 0.6 against a cutoff of 0.4 and the SRA is still pending in 48 hours. What do you do?

Read the worked answer

A weakly positive ELISA in a patient with a 4Ts score of 6 does not exclude HIT; the combination of high pretest probability and any positive result should be managed as HIT.

Actions:

  • Continue the non-heparin anticoagulant; do not restart heparin.
  • Keep the heparin allergy flag active and inform the surgical and anesthesia teams, including for future procedures.
  • Monitor platelets daily - recovery after heparin cessation within about 5 to 7 days supports the diagnosis; failure to recover should prompt a search for another cause or for thrombosis.
  • Screen for thrombosis (Doppler of the legs, appropriate imaging) because HIT is a prothrombotic disorder and roughly half of untreated patients develop thrombosis.
  • Do not send further PF4 ELISAs to monitor; a single functional test is the confirmatory step.

When the SRA returns:

  • Positive - confirm HIT, complete the anticoagulation course, and document a lifelong heparin avoidance.
  • Negative with a falling 4T and platelet recovery - the ELISA was likely a false positive; heparin may be reconsidered only with a clear indication and after haematology review.